Pancreatic Cancer Research

ResearcherUniversity of SurreyActive in the last 2 years

Priyanka Gupta

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-8023-1703; OpenAlex author ID A5011319114. Sources: OpenAlex.

Their work

Papers
12 (first author 6, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
11
Papers, trials and grants by year

2019: 1 paper · 2020: 1 paper · 2021: 3 papers · 2022: none · 2023: 3 papers · 2024: 1 paper · 2025: 1 paper · 2026: 2 papers

Papers 12

  1. Evaluating the impact of dynamic fluid flow on an advanced model of pancreatic cancer: Towards desmoplasia disruption and chemosensitivity promotion. Co-author DOI 10.1016/j.bioadv.2026.214984↗
  2. Correction to "Mapping Tumor-Stroma-ECM Interactions in Spatially Advanced 3D Models of Pancreatic Cancer". First author DOI 10.1021/acsami.6c14723↗
  3. Mapping Tumor-Stroma-ECM Interactions in Spatially Advanced 3D Models of Pancreatic Cancer. First author DOI 10.1021/acsami.5c02296↗
  4. Chemotherapy Assessment in Advanced Multicellular 3D Models of Pancreatic Cancer: Unravelling the Importance of Spatiotemporal Mimicry of the Tumor Microenviro… Co-author DOI 10.1002/adbi.202300580↗
  5. A Step-by-Step Methodological Guide for Developing Zonal Multicellular Scaffold-Based Pancreatic Cancer Models. Co-author DOI 10.1007/978-1-0716-3056-3_13↗
  6. Single-Cell Lipidomics Using Analytical Flow LC-MS Characterizes the Response to Chemotherapy in Cultured Pancreatic Cancer Cells. Co-author DOI 10.1021/acs.analchem.3c02854↗
  7. Enhanced effect of X-rays in the presence of a static magnetic field within a 3D pancreatic cancer model. First author DOI 10.1259/bjr.20220832↗
  8. 3d tissue models as tools for radiotherapy screening for pancreatic cancer. First author DOI 10.1259/bjr.20201397↗
  9. Novel Anticancer and Treatment Sensitizing Compounds against Pancreatic Cancer. First author DOI 10.3390/cancers13122940↗
  10. On the Evaluation of a Novel Hypoxic 3D Pancreatic Cancer Model as a Tool for Radiotherapy Treatment Screening. First author DOI 10.3390/cancers13236080↗
  11. A Novel Scaffold-Based Hybrid Multicellular Model for Pancreatic Ductal Adenocarcinoma-Toward a Better Mimicry of the in vivo Tumor Microenvironment. Co-author DOI 10.3389/fbioe.2020.00290↗
  12. Chemoradiotherapy screening in a novel biomimetic polymer based pancreatic cancer model. Co-author DOI 10.1039/c9ra09123h↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Eirini G. Velliou · 12 shared papers, 2019–2026 · strength 2.73
  2. Pedro Antonio Pérez-Mancera · 6 shared papers, 2019–2026 · strength 1.40
  3. Hemant Mahendrakumar Kocher · 5 shared papers, 2020–2026 · strength 1.30
  4. Giuseppe Schettino · 6 shared papers, 2019–2023 · strength 0.99
  5. Gabrielle Wishart · 4 shared papers, 2021–2023 · strength 0.75
  6. Anna-Dimitra Kataki · 2 shared papers, 2025–2026 · strength 0.58
  7. Yaohe Wang · 2 shared papers, 2025–2026 · strength 0.58
  8. Camino Bermejo‐Rodríguez · 1 shared paper, 2024 · strength 0.28
  9. Melanie Jane Bailey · 1 shared paper, 2023 · strength 0.19
  10. Kyle D. G. Saunders · 1 shared paper, 2023 · strength 0.19
  11. Stella Totti · 1 shared paper, 2019 · strength 0.10

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.